How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of proactive chemistry, manufacturing, and controls strategies.
Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care.
iconPCR is transforming PCR assay development. DOE research that at one point required dozens of plates and long hours at the ...
Doctors can order genetic tests for people at high risk of breast cancer, and insurance often covers those, Kamal says. For ...
In honor of Breast Cancer Awareness Month, the TODAY show, with the help of breast cancer survivors Jill Martin and Sheryl ...
Rapid release testing detects mycoplasma DNA with great sensitivity by using advanced technologies such nucleic acid ...
In 2023, WA announced new regulations prohibiting athletes who have gone through what it called “male puberty” from ...
Background: The co-occurrence of coronary artery disease (CAD) and obstructive sleep apnea (OSA), termed CADOSA, leads to worse clinical outcomes than either condition alone, yet its molecular ...
According to Precedence Research, the global liquid biopsy market size will grow from USD 7.05 billion in 2025 to nearly USD 22.69 billion by 2034, expanding at a strong CAGR of 13.91% from 2025 to ...
M. oryzae Guy11 was used as the wild-type strain in this study. All strains were cultured in CM medium at 28°C under 12-hour light/dark cycles. For the plate growth assay, colony diameters were ...
It's *** small bug with *** big reputation. The kissing bug, once limited to South and Central America, is now moving north. With it comes Chaga's disease, *** parasitic infection Doctor Tim Connolly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback